This announcement is a separate document:
ゼリア新薬工業:[遅延] 2025年3月31日に終了する会計年度の最初の3か月間の連結財務結果 [日本会計基準に基づく]
Zeria Pharmaceutical: [Delay] The consolidated financial results for the first three months of the fiscal year ending on March 31, 2025 [based on Japanese accounting standards].
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.